Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of STDs
4.2.2 Growing Rate of Unintended Pregnancies
4.2.3 Increasing Demand for Modern Contraceptive Methods
4.2.4 Rising Government Initiatives
4.3 Market Restraints
4.3.1 Side Effects of Using Contraception
4.3.2 Socio-cultural Issues Associated with Contraception
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 Product
5.1.1 Drugs
5.1.1.1 Oral Contraceptive Pills
5.1.1.2 Injectable Contraceptives
5.1.1.3 Topical Contraceptives
5.1.2 Devices
5.1.2.1 Condoms
5.1.2.2 Diaphragms
5.1.2.3 Contraceptive Sponges
5.1.2.4 Vaginal Rings
5.1.2.5 Subdermal Implants
5.1.2.6 Intra-uterine Devices
5.2 Gender
5.2.1 Male
5.2.2 Female
5.3 Geography
5.3.1 Europe
5.3.1.1 UK
5.3.1.2 Germany
5.3.1.3 France
5.3.1.4 Italy
5.3.1.5 Spain
5.3.1.6 Rest of Europe


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Actavis PLC
6.1.2 Agile Therapeutics
6.1.3 ANI Pharmaceuticals Inc.
6.1.4 Bayer AG
6.1.5 Fuji Latex Co. Ltd
6.1.6 Johnson & Johnson Ltd
6.1.7 Merck & Co
6.1.8 Pfizer
6.1.9 Teva Pharmaceuticals Ltd
6.1.10 The Female Health Company


7 MARKET OPPORTUNITIES AND FUTURE TRENDS